Artiva Biotherapeutics Inc ARTV インサイダー取引

Artiva Biotherapeutics Inc (ARTV) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-06-25	RA Capital Management, L.P.法人	32.88k	292.13k	買い	8.88 - 8.98	17.96M	0.18%
2026-06-12	RA Capital Management, L.P.法人	531.33k	4.60M	買い	8.57 - 8.99	17.92M	3.06%
2026-06-09	RA Capital Management, L.P.法人	1.43M	11.14M	買い	6.91 - 8.99	68.32k	-105.00%
2026-06-09	RA Capital Management, L.P.法人	1.03M	7.65M	買い	6.91 - 7.91	17.39M	6.28%
2026-05-11	GC Cell Corporation法人	1.43M	16.50M	買い	11.52	6.00M	31.36%
2026-05-19	Dr. Heather RaymonSVP of Research & Early Development	-3.10k	27.88k	売り	9.01	148.23k	-2.05%
2026-05-19	Mr. Christopher P. HoranChief Technical Operations Officer	-7.00k	63.07k	売り	9.01	293.45k	-2.33%
2026-05-19	Ms. Jennifer Kinsbruner BushCOO	-8.79k	79.18k	売り	9.01	20.97k	-29.54%
2026-05-19	Dr. Subhashis BanerjeeChief Medical Officer	-7.04k	63.39k	売り	9.01	144.96k	-4.63%
2026-05-19	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-27.12k	244.25k	売り	9.01	1.54M	-1.74%
2026-05-11	RA Capital Management, L.P.法人	6.51M	75.00M	買い	11.52	15.20M	74.89%
2026-05-11	RA Capital Management, L.P.法人	2.17M	0.00	Open Market Derivative Acquisition	0.00	2.17M	-
2026-05-11	RA Capital Management, L.P.法人	6.51M	75.00M	買い	11.52	68.32k	-101.06%
2026-02-15	Dr. Heather RaymonSVP of Research & Early Development	-1.52k	6.08k	Sale to Issuer	4.00	151.32k	-1.00%
2026-02-15	Mr. Christopher P. HoranChief Technical Operations Officer	-2.19k	8.75k	Sale to Issuer	4.00	300.45k	-0.72%
2026-02-15	Ms. Jennifer Kinsbruner BushCOO	-3.52k	14.06k	Sale to Issuer	4.00	26.63k	-11.66%
2026-02-15	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-14.60k	58.40k	Sale to Issuer	4.00	1.56M	-0.93%
2025-12-15	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-3.19k	19.12k	Automatic Disposition	6.00	1.21M	-0.26%
2025-11-15	Mr. Christopher P. HoranChief Technical Operations Officer	-1.90k	6.17k	Sale to Issuer	3.25	78.18k	-2.37%
2025-11-15	Dr. Heather RaymonSVP of Research & Early Development	-1.38k	4.47k	Sale to Issuer	3.25	39.59k	-3.36%
2025-11-15	Ms. Jennifer Kinsbruner BushCOO	-3.06k	9.93k	Sale to Issuer	3.25	18.84k	-13.95%
2025-11-17	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-6.38k	21.52k	Automatic Disposition	3.38	344.00k	-1.82%
2025-11-15	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-6.35k	20.63k	Sale to Issuer	3.25	344.00k	-1.81%
2025-11-15	Ms. Neha Krishnamohanインサイダー	-3.49k	11.34k	Sale to Issuer	3.25	19.36k	-15.28%
2025-10-17	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-25.50k	153.00k	Automatic Disposition	6.00	356.72k	-6.67%
2025-05-15	Ms. Jennifer Kinsbruner BushCOO	-8.35k	21.75k	Sale to Issuer	2.13 - 2.75	14.45k	-36.61%
2025-05-15	Mr. Christopher P. HoranChief Technical Operations Officer	-4.92k	12.69k	Sale to Issuer	2.13 - 2.75	80.08k	-5.79%
2025-05-15	Ms. Neha Krishnamohanインサイダー	-7.15k	18.84k	Sale to Issuer	2.13 - 2.75	15.97k	-30.94%
2025-05-15	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-8.94k	21.82k	Sale to Issuer	2.13 - 2.75	382.22k	-2.29%
2025-05-15	Dr. Heather RaymonSVP of Research & Early Development	-2.38k	6.09k	Sale to Issuer	2.13 - 2.75	40.97k	-5.50%
2025-08-15	Dr. Fred AslanCEO, Principal Financial & Accounting Officer and Director	-25.50k	69.58k	Automatic Disposition	2.73	382.22k	-6.25%